Skip to content
← Back to this collection

PUBLICATIONS · 28980004

Brentuximab Vedotin for Patients With Refractory Lymphomatoid Papulosis: An Analysis of Phase 2 Results.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
JAMA Dermatol
Publication date
2017 Dec 1
First author
Lewis DJ

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Lewis DJ
      type
      Author
    2. name
      Talpur R
      type
      Author
    3. name
      Huen AO
      type
      Author
    4. name
      Tetzlaff MT
      type
      Author
    5. name
      Duvic M
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Lewis DJ
      type
      Author
    2. name
      Talpur R
      type
      Author
    3. name
      Huen AO
      type
      Author
    4. name
      Tetzlaff MT
      type
      Author
    5. name
      Duvic M
      type
      Author
    bibliography ids
    1. nci-bib-8774b983cb20229e513911e4
    book metadata
    content sha256
    14c15d6ad2ec9a5ab06259187bf96c509005ad05678ddf3f6c9883eaf8457f35
    document type
    citation
    dois
    1. 10.1001/jamadermatol.2017.3593
    electronic publication date
    display
    Source null
    precision
    missing
    year
    Source null
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:28980004
    immutable id
    pubmed:28980004@14c15d6ad2ec9a5ab06259187bf96c509005ad05678ddf3f6c9883eaf8457f35
    journal
    abbreviation
    JAMA Dermatol
    issn electronic
    2168-6084
    issn print
    2168-6068
    issue
    12
    name
    JAMA dermatology
    nlm unique id
    101589530
    pages
    1302-1306
    volume
    153
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      28980004
      provenance
      batch id
      fb25b16edcb1373b70c1
      provider
      NCBI PubMed ESummary
      record sha256
      c5dd20a1cf0a978fb3e74cd83e55e88ef3e7ab9a231da5ecc80038823003f073
      response sha256
      182c99bf1974b58308315b66aa28d31c61e8fc31cf3de4cadb0340a4f6734c52
      retrieved at
      2026-09-09T23:47:28.490065+00:00
      publication date
      display
      2017 Dec 1
      precision
      day
      year
      2017
      publication types
      1. Clinical Trial, Phase II
      2. Journal Article
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/28980004/
      title
      Brentuximab Vedotin for Patients With Refractory Lymphomatoid Papulosis: An Analysis of Phase 2 Results.

      Preserved source evidence · Not medical advice